Ad
related to: ngm
Search results
NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks via Yahoo Finance· 1 year agoNGM Biopharmaceuticals (NGM) possesses the right combination of the two key ingredients for a likely...
NGM Biopharmaceuticals (NGM) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 10 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 0% and 42.30%,...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is definitely on the radar of institutional investors who...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), it is...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) insider upped their holding by 68% earlier this year
Simply Wall St. via Yahoo Finance· 1 year agoLooking at NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM ) insider transactions over the last year, we...
Why NGM Biopharmaceuticals (NGM) Might Surprise This Earnings Season
Zacks via Yahoo Finance· 3 months agoNGM Biopharmaceuticals (NGM) is seeing favorable earnings estimate revision activity and has a...
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock price...
NGM Biopharmaceuticals Inc (NGM) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoNGM Biopharmaceuticals Inc (NASDAQ:NGM) reported a net loss of $28.8 million for Q3 2023, compared...
NGM to go private through deal with investment firm
BioPharma Dive via Yahoo Finance· 3 months agoThe deal would mark a retreat from public markets for the once notable biotech, which was forced to cut staff last year to save cash after trial...
Institutional owners may consider drastic measures as NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM)...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significantly high institutional ownership implies NGM Biopharmaceuticals' stock price...
Shareholders in NGM Biopharmaceuticals (NASDAQ:NGM) have lost 42%, as stock drops 6.5% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors can approximate the average market return by buying an index fund. While individual stocks...